603658.SS
603658.SS
CNE100002GC4
AUTOBIO DIAGNOSTICS CO LTD
Loading chart...

Company Profile

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an automatic immunoassay analyzer; AutoLumo A2000 Plus, an automated chemiluminescence immunoassay analyzer; PHOmo microplate readers; LUmo microplate luminometers; and iWO-960 microplate washers. The company's microbiology products include AutoMic-I60 for microbial identification and antibiotic susceptibility testing; AutoStreak S1800, a microbial sample pretreatment system; Autof T series and MALDI-TOF MS system for the identification of pathogenic bacteria; AutoMimo 1200, an instrument for improving pipetting efficiency and optimize workflow in the lab; BC60, an automatic blood culture instrument; and BC120, an automated bacterial culturing and detection. It also provides blood culture bottles and mycoplasma TIES reagents; AutoMolec 1600, an integrated and automated molecular diagnostics analyzer; AutoMolec 3000, an in vitro molecular detection instrument; Ci-120x and Ci-310 benchtop coagulation analyzers; and Autolas Bi 1000, Autolas Bi2600, AutoChem B861, and AutoChem B2000 automated biochemistry analyzers, as well as Autolas X series, and Autolas B series. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is headquartered in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Autobio Co., Ltd.

Related stocks

300003.SZ
300003.SZ • China
LEPU MEDICAL
11.68 CNY
3.22B USD 1Y -32.7%
002901.SZ
002901.SZ • China
DOUBLE MEDICAL
40.08 CNY
2.48B USD 1Y -31.1%
002223.SZ
002223.SZ • China
YUYUE MEDICAL
26.12 CNY
3.89B USD 1Y -33%
2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD
688016.SS
688016.SS • China
SHANGHAI MICROPORT ENDOVASCULAR
84.9 CNY
1.57B USD 1Y -24.7%
688198.SS
688198.SS • China
BEIJING BALANCE MEDICAL TECHNOL
69.83 CNY
1.44B USD 1Y -33.7%
688114.SS
688114.SS • China
MGI TECH CO LTD
67.95 CNY
4.23B USD 1Y -4.7%
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.6% p.a.
Max Drawdown (5Y)
-63.7%
Sharpe Ratio (5Y)
-0.34
Beta Factor
0.00
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -79.0% in the extended horizon.
ende